
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1360 | 1134 | 1360 | 1395 | 2184 | 3989 |
Fund Return | 36% | 13.39% | 36% | 11.72% | 16.91% | 14.84% |
Place in category | 75 | 83 | 75 | 33 | 38 | 19 |
% in Category | 60 | 70 | 60 | 37 | 44 | 32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BTG Pactual Chile Accion B | 155.06B | 11.53 | 23.97 | 7.09 | ||
BTG Pactual Chile Accion B APV | 155.06B | 11.87 | 24.86 | 8.09 | ||
BTG Pactual Acciones USA I | 17.21B | 35.74 | 11.51 | 14.62 | ||
BTG Pactual Global Desarrollado B | 8.89B | 25.63 | 4.43 | 8.21 | ||
BTG Pactual Global Desarrollado B A | 8.89B | 26.98 | 5.66 | 9.49 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal USA Equity B | 355.55B | -4.93 | 14.90 | 14.07 | ||
Euroamerica USA D | 143.78B | 36.64 | 10.99 | 15.30 | ||
Inversion USA B | 113.37B | 38.21 | 11.47 | 15.12 | ||
BBVA USA APV | 96.57B | 46.14 | 14.06 | 17.75 | ||
Sura Seleccion Acciones USA C | 44.13B | 39.93 | 11.82 | 14.86 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vanguard S&P 500 ETF | - | 21.68 | - | - | |
Trp Health Sciences Portfolio | - | 19.60 | - | - | |
Source S&P 500 UCITS | IE00B3YCGJ38 | 18.10 | 1,061.26 | -1.03% | |
iShares Core S&P 500 UCITS | IE00B5BMR087 | 15.22 | 570.44 | -1.10% | |
JPMorgan Investment Funds - US Select Equity Fund | LU0070214290 | 13.93 | 731.790 | +0.13% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | BUY | Strong Sell | BUY |
Summary | Neutral | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review